Page last updated: 2024-08-20

dextrothyroxine and lopinavir

dextrothyroxine has been researched along with lopinavir in 14 studies

Research

Studies (14)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	14 (100.00)	2.80

Authors

Authors	Studies
Şimşek Yavuz, S; Ünal, S	1
Anastasiou, IA; Eleftheriadou, I; Tentolouris, A; Tentolouris, N; Tsilingiris, D	1
Mishra, SK; Tripathi, T	1
Kumar, D; Trivedi, N; Verma, A	1
Dadvand, H; Davoodian, P; Fathalipour, M; Ghazizadeh, S; Hassaniazad, M; Hassanipour, S; Hosseini, FS; Kahoori, S; Malektojari, A; Nikoofal-Sahlabadi, S; Nikpoor, AR; Sepandi, M	1
Wen, S; Xu, X; Yadav, AK; Yu, L	1
Arouche, TDS; Costa, FLP; Filho, TSA; Júnior, RNC; Martins, AY; Neto, AMJC; Ramalho, TC	1
Chandra, PP; Jain, S; Potschka, H; Tripathi, M; Vohora, D	1
Arabi, M; Bitar, F; Eid, AH; Fakhri, G; Younis, NK; Zareef, RO	1
Bhardwaj, M; Chiu, MN; Sah, SP	1
Abdullahi, A; Abdullahi, M; Atiku, A; Dauda, H; Gwamna, J; Ige, O; Kambai, H; Kera, HN; Musa, S; Olasinde, T; Oyefabi, A; Sheyin, J; Sunday, J; Umeh, GC; Usman, I	1
Atal, S; Kaore, S	1
Alsmadi, MM	1
Chen, J; Cheng, Q; Fang, Z; Jia, Q; Zhao, G	1

Reviews

9 review(s) available for dextrothyroxine and lopinavir

Article	Year
Antiviral treatment of COVID-19 Turkish journal of medical sciences, 2020, 04-21, Volume: 50, Issue:SI-1 Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Humans; Hydroxychloroquine; Ivermectin; Lopinavir; Nitro Compounds; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; SARS-CoV-2; Thiazoles	2020
One year update on the COVID-19 pandemic: Where are we now? Acta tropica, 2021, Volume: 214 Topics: Adenosine Monophosphate; Alanine; Amides; Animals; Antiviral Agents; Chloroquine; Clinical Trials as Topic; Coronavirus; Coronavirus Infections; COVID-19; COVID-19 Vaccines; Drug Combinations; Drug Repositioning; Glucocorticoids; Humans; Hydroxychloroquine; Indoles; Ivermectin; Lopinavir; Mutation; Pandemics; Phytotherapy; Plant Extracts; Pyrazines; Ritonavir; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Tinospora; Viral Zoonoses	2021
Possible treatment and strategies for COVID-19: review and assessment. European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:23 Topics: Adenosine Monophosphate; Alanine; Amides; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antibodies, Neutralizing; Antiparasitic Agents; Antiviral Agents; Cannabinoids; Chloroquine; Complement Inactivating Agents; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; COVID-19 Vaccines; Dexamethasone; Drug Combinations; Enzyme Inhibitors; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferons; Ivermectin; Lopinavir; Nitro Compounds; Pyrazines; Ritonavir; SARS-CoV-2; Teicoplanin; Tetracyclines; Thiazoles	2020
Antiviral treatment in COVID-19: which is the most promising?-a narrative review. Annals of palliative medicine, 2021, Volume: 10, Issue:1 Topics: Adenosine Monophosphate; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azetidines; Chloroquine; COVID-19; COVID-19 Serotherapy; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferons; Ivermectin; Lopinavir; Nitro Compounds; Oseltamivir; Purines; Pyrazines; Pyrazoles; Ribavirin; Ritonavir; Sulfonamides; Thiazoles	2021
Management of COVID-19 in patients with seizures: Mechanisms of action of potential COVID-19 drug treatments and consideration for potential drug-drug interactions with anti-seizure medications. Epilepsy research, 2021, Volume: 174 Topics: Adenosine Monophosphate; Alanine; Amides; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Anticonvulsants; Antiviral Agents; Chloroquine; COVID-19; COVID-19 Drug Treatment; Cytochrome P-450 CYP3A Inducers; Dexamethasone; Drug Combinations; Drug Interactions; Enzyme Inhibitors; Epilepsy; Glucocorticoids; Humans; Hydroxychloroquine; Interleukin 1 Receptor Antagonist Protein; Ivermectin; Lopinavir; Pyrazines; Ritonavir; SARS-CoV-2	2021
COVID-19: potential therapeutics for pediatric patients. Pharmacological reports : PR, 2021, Volume: 73, Issue:6 Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azithromycin; Child; COVID-19 Drug Treatment; Dexamethasone; Humans; Hydroxychloroquine; Ivermectin; Lopinavir; Oseltamivir; SARS-CoV-2; Spike Glycoprotein, Coronavirus	2021
Safety profile of COVID-19 drugs in a real clinical setting. European journal of clinical pharmacology, 2022, Volume: 78, Issue:5 Topics: Antiviral Agents; Chloroquine; COVID-19 Drug Treatment; Dexamethasone; Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxychloroquine; Ivermectin; Lopinavir; Reproducibility of Results; Ritonavir; SARS-CoV-2	2022
Molnupiravir in COVID-19: A Scoping Review. Current drug research reviews, 2022, Volume: 14, Issue:3 Topics: Adrenal Cortex Hormones; Animals; Antiviral Agents; COVID-19 Drug Treatment; Cricetinae; Ferrets; Humans; Hydroxychloroquine; Ivermectin; Lopinavir; Mice; Ritonavir; RNA-Dependent RNA Polymerase; SARS-CoV-2	2022
Comparative efficacy and safety of pharmacological interventions for severe COVID-19 patients: An updated network meta-analysis of 48 randomized controlled trials. Medicine, 2022, Oct-14, Volume: 101, Issue:41 Topics: Colchicine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Doxycycline; Humans; Imatinib Mesylate; Immunization, Passive; Immunoglobulins, Intravenous; Interferon beta-1b; Ivermectin; Lopinavir; Methylprednisolone; Network Meta-Analysis; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; Ritonavir	2022

Trials

1 trial(s) available for dextrothyroxine and lopinavir

Article	Year
The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial. Trials, 2021, Jan-04, Volume: 22, Issue:1 Topics: Administration, Oral; Adult; Antiviral Agents; Clinical Trials, Phase III as Topic; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Intensive Care Units; Interferon beta-1a; Iran; Ivermectin; Length of Stay; Lopinavir; Male; Randomized Controlled Trials as Topic; Ritonavir; SARS-CoV-2; Severity of Illness Index	2021

Article

Year

The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial.

Trials, 2021, Jan-04, Volume: 22, Issue:1

Topics: Administration, Oral; Adult; Antiviral Agents; Clinical Trials, Phase III as Topic; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Intensive Care Units; Interferon beta-1a; Iran; Ivermectin; Length of Stay; Lopinavir; Male; Randomized Controlled Trials as Topic; Ritonavir; SARS-CoV-2; Severity of Illness Index

2021

Other Studies

4 other study(ies) available for dextrothyroxine and lopinavir

Article	Year
In Vitro Data of Current Therapies for SARS-CoV-2. Current medicinal chemistry, 2020, Volume: 27, Issue:27 Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; China; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Emetine; Homoharringtonine; Humans; Hydroxychloroquine; Ivermectin; Lopinavir; Nitro Compounds; Pandemics; Pneumonia, Viral; SARS-CoV-2; Teicoplanin; Thiazoles	2020
Molecular Docking of Azithromycin, Ritonavir, Lopinavir, Oseltamivir, Ivermectin and Heparin Interacting with Coronavirus Disease 2019 Main and Severe Acute Respiratory Syndrome Coronavirus-2 3C-Like Proteases. Journal of nanoscience and nanotechnology, 2021, 04-01, Volume: 21, Issue:4 Topics: Azithromycin; Coronavirus 3C Proteases; COVID-19; Heparin; Humans; Ivermectin; Lopinavir; Molecular Docking Simulation; Oseltamivir; Ritonavir; SARS-CoV-2	2021
Comparison of the Ivermectin and Lopinavir/Ritonavir Treatment Outcomes among COVID-19 Mild to Moderate Cases in Kaduna State. West African journal of medicine, 2022, Feb-28, Volume: 39, Issue:2 Topics: COVID-19 Drug Treatment; Cross-Sectional Studies; HIV Infections; Humans; Ivermectin; Lopinavir; Nigeria; Ritonavir; SARS-CoV-2; Treatment Outcome	2022
The investigation of the complex population-drug-drug interaction between ritonavir-boosted lopinavir and chloroquine or ivermectin using physiologically-based pharmacokinetic modeling. Drug metabolism and personalized therapy, 2023, 03-01, Volume: 38, Issue:1 Topics: Adult; Chloroquine; COVID-19; COVID-19 Drug Treatment; Cytochrome P-450 CYP3A; Drug Interactions; Humans; Ivermectin; Lopinavir; Ritonavir	2023